2026 Global: Biocontrol Market-Competitive Review (2032) report
Description
The 2026 Global: Biocontrol Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biocontrol market by geography and historical trend. The scope of the report extends to sizing of the biocontrol market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The biocontrol market features leading companies like RovensaNext, BioFirst, Corteva Agriscience, Koppert Biological Systems, and Syngenta Biologicals, which dominate through innovative biological solutions for pest management and crop protection. RovensaNext positions itself as the global leader in biosolutions, targeting €1 billion in revenue by 2025 with brands like TradeCorp and Agro K, employing 2,000 people worldwide and focusing on agricultural biocontrol, bionutrition, and adjuvants. BioFirst, a pure player in biologicals, oversees BioBest's bumblebee pollination and biocontrol expertise since 1987, reporting over €500 million in revenue across 32 subsidiaries and 2,800 employees, bolstered by its 2023 $532 million acquisition of Biotrop. Corteva Agriscience integrates biocontrol into integrated pest management, offering microbial and botanical solutions like BlueN to enhance plant health amid North America's growing market projected to reach USD 218.8 million by 2030.
Koppert Biological Systems, a family-owned Dutch firm since 1967, leads in macroorganisms with €417 million turnover and 2,635 employees across 34 countries, setting benchmarks in portfolio breadth. Syngenta Biologicals advances biofungicides like BotriStop through partnerships, such as with Botanical Solution Inc., while expanding biostimulants for sustainable farming in regulated markets like Europe. BASF Agricultural Solutions develops biofungicides, biopesticides, and growth-promoting microbes via partnerships with Elicit Plant and Acadian, emphasizing resistance management and residue reduction. Certis Biologicals commercializes innovations like NemaClean nematicide, registered in the EU in March 2025, and collaborates with SDS Biotech for crop protection, focusing on microbial insecticides and licensing.
Other majors include UPL with Natural Plant Protection and partnerships like ZOATIN for phosphorus uptake, Bayer CropScience blending biologicals with IPM via Serenade, and Valent BioSciences offering microbial solutions amid a fragmented market favoring incumbents with R&D investments. FMC and De Sangosse contribute through research in North America, where microbials hold leadership with 8.9% CAGR, driven by EPA approvals and subsidies. These firms navigate consolidation, with Sumitomo's investments in DPH Biologicals signaling U.S. expansion in a sector growing at 8.3% CAGR to US$9.84 billion by 2034, prioritizing sustainability over chemicals.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biocontrol market by geography and historical trend. The scope of the report extends to sizing of the biocontrol market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The biocontrol market features leading companies like RovensaNext, BioFirst, Corteva Agriscience, Koppert Biological Systems, and Syngenta Biologicals, which dominate through innovative biological solutions for pest management and crop protection. RovensaNext positions itself as the global leader in biosolutions, targeting €1 billion in revenue by 2025 with brands like TradeCorp and Agro K, employing 2,000 people worldwide and focusing on agricultural biocontrol, bionutrition, and adjuvants. BioFirst, a pure player in biologicals, oversees BioBest's bumblebee pollination and biocontrol expertise since 1987, reporting over €500 million in revenue across 32 subsidiaries and 2,800 employees, bolstered by its 2023 $532 million acquisition of Biotrop. Corteva Agriscience integrates biocontrol into integrated pest management, offering microbial and botanical solutions like BlueN to enhance plant health amid North America's growing market projected to reach USD 218.8 million by 2030.
Koppert Biological Systems, a family-owned Dutch firm since 1967, leads in macroorganisms with €417 million turnover and 2,635 employees across 34 countries, setting benchmarks in portfolio breadth. Syngenta Biologicals advances biofungicides like BotriStop through partnerships, such as with Botanical Solution Inc., while expanding biostimulants for sustainable farming in regulated markets like Europe. BASF Agricultural Solutions develops biofungicides, biopesticides, and growth-promoting microbes via partnerships with Elicit Plant and Acadian, emphasizing resistance management and residue reduction. Certis Biologicals commercializes innovations like NemaClean nematicide, registered in the EU in March 2025, and collaborates with SDS Biotech for crop protection, focusing on microbial insecticides and licensing.
Other majors include UPL with Natural Plant Protection and partnerships like ZOATIN for phosphorus uptake, Bayer CropScience blending biologicals with IPM via Serenade, and Valent BioSciences offering microbial solutions amid a fragmented market favoring incumbents with R&D investments. FMC and De Sangosse contribute through research in North America, where microbials hold leadership with 8.9% CAGR, driven by EPA approvals and subsidies. These firms navigate consolidation, with Sumitomo's investments in DPH Biologicals signaling U.S. expansion in a sector growing at 8.3% CAGR to US$9.84 billion by 2034, prioritizing sustainability over chemicals.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
